Annual Retained Earnings:
$9.61B-$535.60M(-5.28%)Summary
- As of today, VRTX annual retained earnings is $9.61 billion, with the most recent change of -$535.60 million (-5.28%) on December 31, 2024.
- During the last 3 years, VRTX annual retained earnings has risen by +$6.41 billion (+200.14%).
- VRTX annual retained earnings is now -5.28% below its all-time high of $10.14 billion, reached on December 31, 2023.
Performance
VRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
$12.37B+$1.08B(+9.60%)Summary
- As of today, VRTX quarterly retained earnings is $12.37 billion, with the most recent change of +$1.08 billion (+9.60%) on September 30, 2025.
- Over the past year, VRTX quarterly retained earnings has increased by +$3.68 billion (+42.27%).
- VRTX quarterly retained earnings is now at all-time high.
Performance
VRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
VRTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -5.3% | +42.3% |
| 3Y3 Years | +200.1% | +116.8% |
| 5Y5 Years | +618.5% | +4760.5% |
VRTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -5.3% | +200.1% | at high | +116.8% |
| 5Y | 5-Year | -5.3% | +618.5% | at high | +4760.5% |
| All-Time | All-Time | -5.3% | +278.8% | at high | +328.8% |
VRTX Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $12.37B(+9.6%) |
| Jun 2025 | - | $11.29B(+10.1%) |
| Mar 2025 | - | $10.25B(+6.7%) |
| Dec 2024 | $9.61B(-5.3%) | $9.61B(+10.5%) |
| Sep 2024 | - | $8.69B(+13.7%) |
| Jun 2024 | - | $7.65B(-32.0%) |
| Mar 2024 | - | $11.24B(+10.8%) |
| Dec 2023 | $10.14B(+55.5%) | $10.14B(+10.6%) |
| Sep 2023 | - | $9.17B(+12.7%) |
| Jun 2023 | - | $8.14B(+12.7%) |
| Mar 2023 | - | $7.22B(+10.7%) |
| Dec 2022 | $6.52B(+103.8%) | $6.52B(+14.4%) |
| Sep 2022 | - | $5.70B(+19.5%) |
| Jun 2022 | - | $4.77B(+20.5%) |
| Mar 2022 | - | $3.96B(+23.8%) |
| Dec 2021 | $3.20B(+272.7%) | $3.20B(+31.7%) |
| Sep 2021 | - | $2.43B(+54.0%) |
| Jun 2021 | - | $1.58B(+4.4%) |
| Mar 2021 | - | $1.51B(+76.1%) |
| Dec 2020 | $858.70M(+146.3%) | $858.67M(+237.4%) |
| Sep 2020 | - | $254.48M(+161.6%) |
| Jun 2020 | - | -$412.95M(+67.0%) |
| Mar 2020 | - | -$1.25B(+32.5%) |
| Dec 2019 | -$1.85B(+38.0%) | -$1.85B(+23.9%) |
| Sep 2019 | - | -$2.44B(+2.3%) |
| Jun 2019 | - | -$2.49B(+9.7%) |
| Mar 2019 | - | -$2.76B(+7.6%) |
| Dec 2018 | -$2.99B(+41.6%) | -$2.99B(+34.2%) |
| Sep 2018 | - | -$4.54B(+2.8%) |
| Jun 2018 | - | -$4.67B(+4.3%) |
| Mar 2018 | - | -$4.88B(+4.8%) |
| Dec 2017 | -$5.12B(+4.7%) | -$5.12B(+1.9%) |
| Sep 2017 | - | -$5.22B(-2.0%) |
| Jun 2017 | - | -$5.12B(+0.4%) |
| Mar 2017 | - | -$5.14B(+4.4%) |
| Dec 2016 | -$5.37B(-2.1%) | -$5.37B(+0.6%) |
| Sep 2016 | - | -$5.41B(-0.7%) |
| Jun 2016 | - | -$5.37B(-1.2%) |
| Mar 2016 | - | -$5.30B(-0.8%) |
| Dec 2015 | -$5.26B(-11.8%) | -$5.26B(-1.4%) |
| Sep 2015 | - | -$5.19B(-1.9%) |
| Jun 2015 | - | -$5.09B(-3.9%) |
| Mar 2015 | - | -$4.90B(-4.2%) |
| Dec 2014 | -$4.71B(-18.6%) | -$4.71B(-3.9%) |
| Sep 2014 | - | -$4.53B(-3.9%) |
| Jun 2014 | - | -$4.36B(-3.8%) |
| Mar 2014 | - | -$4.20B(-5.9%) |
| Dec 2013 | -$3.97B(-12.6%) | -$3.97B(+1.1%) |
| Sep 2013 | - | -$4.01B(-3.2%) |
| Jun 2013 | - | -$3.89B(-1.5%) |
| Mar 2013 | - | -$3.83B(-8.7%) |
| Dec 2012 | -$3.52B(-3.1%) | -$3.52B(-2.2%) |
| Sep 2012 | - | -$3.45B(-1.7%) |
| Jun 2012 | - | -$3.39B(-2.0%) |
| Mar 2012 | - | -$3.32B(+2.7%) |
| Dec 2011 | -$3.41B(+0.9%) | -$3.41B(+4.4%) |
| Sep 2011 | - | -$3.57B(+5.8%) |
| Jun 2011 | - | -$3.79B(-4.8%) |
| Mar 2011 | - | -$3.62B(-5.1%) |
| Dec 2010 | -$3.44B(-28.1%) | -$3.44B(-5.5%) |
| Sep 2010 | - | -$3.26B(-6.8%) |
| Jun 2010 | - | -$3.06B(-7.0%) |
| Mar 2010 | - | -$2.86B(-6.1%) |
| Dec 2009 | -$2.69B(-31.4%) | -$2.69B(-6.3%) |
| Sep 2009 | - | -$2.53B(-6.3%) |
| Jun 2009 | - | -$2.38B(-7.8%) |
| Mar 2009 | - | -$2.21B(-7.9%) |
| Dec 2008 | -$2.05B | -$2.05B(-7.5%) |
| Sep 2008 | - | -$1.91B(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | -$1.78B(-5.4%) |
| Mar 2008 | - | -$1.68B(-6.1%) |
| Dec 2007 | -$1.59B(-32.7%) | -$1.59B(-5.7%) |
| Sep 2007 | - | -$1.50B(-7.7%) |
| Jun 2007 | - | -$1.39B(-9.2%) |
| Mar 2007 | - | -$1.28B(-6.7%) |
| Dec 2006 | -$1.20B(-20.9%) | -$1.20B(-2.3%) |
| Sep 2006 | - | -$1.17B(-4.6%) |
| Jun 2006 | - | -$1.12B(-7.5%) |
| Mar 2006 | - | -$1.04B(-5.1%) |
| Dec 2005 | -$989.58M(-25.9%) | -$989.58M(-4.0%) |
| Sep 2005 | - | -$951.45M(-9.1%) |
| Jun 2005 | - | -$871.88M(-4.9%) |
| Mar 2005 | - | -$830.89M(-5.7%) |
| Dec 2004 | -$786.17M(-26.8%) | -$786.17M(-5.8%) |
| Sep 2004 | - | -$743.40M(-5.5%) |
| Jun 2004 | - | -$704.63M(-6.7%) |
| Mar 2004 | - | -$660.36M(-6.5%) |
| Dec 2003 | -$619.92M(-46.5%) | -$619.92M(-7.1%) |
| Sep 2003 | - | -$578.89M(-17.5%) |
| Jun 2003 | - | -$492.47M(-22.3%) |
| Mar 2003 | - | -$402.54M(+4.9%) |
| Dec 2002 | -$423.15M(-34.5%) | -$423.15M(-8.2%) |
| Sep 2002 | - | -$391.07M(-9.4%) |
| Jun 2002 | - | -$357.62M(-6.2%) |
| Mar 2002 | - | -$336.60M(-7.0%) |
| Dec 2001 | -$314.53M(-26.7%) | -$314.53M(-1.0%) |
| Sep 2001 | - | -$311.27M(-23.8%) |
| Jun 2001 | - | -$251.46M(-5.1%) |
| Mar 2001 | - | -$239.35M(-3.8%) |
| Dec 2000 | -$248.30M(-30.1%) | -$230.49M(-5.1%) |
| Sep 2000 | - | -$219.23M(-12.8%) |
| Jun 2000 | - | -$194.37M(+6.1%) |
| Mar 2000 | - | -$206.99M(-8.5%) |
| Dec 1999 | -$190.83M(-27.3%) | -$190.83M(+0.9%) |
| Sep 1999 | - | -$192.54M(-8.0%) |
| Jun 1999 | - | -$178.26M(-6.5%) |
| Mar 1999 | - | -$167.41M(-11.7%) |
| Dec 1998 | -$149.90M(-28.3%) | -$149.86M(-9.2%) |
| Sep 1998 | - | -$137.26M(-1.7%) |
| Jun 1998 | - | -$134.99M(-7.8%) |
| Mar 1998 | - | -$125.19M(-7.2%) |
| Dec 1997 | -$116.80M(-20.5%) | -$116.80M(-6.2%) |
| Sep 1997 | - | -$110.00M(-5.7%) |
| Jun 1997 | - | -$104.10M(-1.4%) |
| Mar 1997 | - | -$102.70M(-6.0%) |
| Dec 1996 | -$96.90M(-70.3%) | -$96.90M(-4.1%) |
| Sep 1996 | - | -$93.10M(-7.4%) |
| Jun 1996 | - | -$86.70M(-34.6%) |
| Mar 1996 | - | -$64.40M(-13.2%) |
| Dec 1995 | -$56.90M(-60.7%) | -$56.90M(-1.4%) |
| Sep 1995 | - | -$56.10M(-14.3%) |
| Jun 1995 | - | -$49.10M(-22.4%) |
| Mar 1995 | - | -$40.10M(-13.3%) |
| Dec 1994 | -$35.40M(-98.9%) | -$35.40M(-16.1%) |
| Sep 1994 | - | -$30.50M(-14.7%) |
| Jun 1994 | - | -$26.60M(-26.1%) |
| Mar 1994 | - | -$21.10M(-18.5%) |
| Dec 1993 | -$17.80M(+10.6%) | -$17.80M(+33.1%) |
| Sep 1993 | - | -$26.60M(-11.3%) |
| Jun 1993 | - | -$23.90M(-3.0%) |
| Mar 1993 | - | -$23.20M(-16.6%) |
| Dec 1992 | -$19.90M(-74.6%) | -$19.90M(-15.7%) |
| Sep 1992 | - | -$17.20M(-15.4%) |
| Jun 1992 | - | -$14.90M(-14.6%) |
| Mar 1992 | - | -$13.00M(-14.0%) |
| Dec 1991 | -$11.40M(-83.9%) | -$11.40M(-14.0%) |
| Sep 1991 | - | -$10.00M(-13.6%) |
| Jun 1991 | - | -$8.80M(-41.9%) |
| Dec 1990 | -$6.20M | -$6.20M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual retained earnings?
- What is the all-time high annual retained earnings for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual retained earnings year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual retained earnings?
The current annual retained earnings of VRTX is $9.61B
What is the all-time high annual retained earnings for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual retained earnings is $10.14B
What is Vertex Pharmaceuticals Incorporated annual retained earnings year-on-year change?
Over the past year, VRTX annual retained earnings has changed by -$535.60M (-5.28%)
What is Vertex Pharmaceuticals Incorporated quarterly retained earnings?
The current quarterly retained earnings of VRTX is $12.37B
What is the all-time high quarterly retained earnings for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly retained earnings is $12.37B
What is Vertex Pharmaceuticals Incorporated quarterly retained earnings year-on-year change?
Over the past year, VRTX quarterly retained earnings has changed by +$3.68B (+42.27%)